Search Orphan Drug Designations and Approvals
-
| Generic Name: | AAV9-Synapsin-Caveolin-1 |
|---|---|
| Date Designated: | 09/28/2022 |
| Orphan Designation: | Treatment of Amyotrophic Lateral Sclerosis (ALS) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Eikonoklastes Therapeutics, Inc. 2356 Park Ave., #17 Cincinnati, Ohio 45206-2725 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







